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Abstract
Background: Family planning services have been available at no cost in the public health settings of South Africa
since 1994, and now include the long-acting reversible contraceptives (LARCs) namely, the contraceptive implant
and intra-uterine device (IUD). However, the uptake of LARCs has been declining in the recent years and little is
known about the cause of the decline. In many relationships, men may influence their female intimate partner’s
contraceptive choices. Thus, men’s involvement in reproductive health decisions and family programming may
improve their support for contraceptive use, including the LARC use by their female intimate partners. This study
investigated factors affecting men’s support for the use of contraceptive implant by their female intimate partners.
Methods: A quantitative, cross-sectional survey was conducted among adult men attending a public, primary
health clinic in Cape Town, South Africa. Using a structured questionnaire, we measured men’s knowledge,
awareness and support of, and attitudes towards use of the contraceptive implant by their female intimate partners.
Data were analyzed using SPSS version 25.
Results: The sample included 65 men with a mean age of 31.2 years. Most (76.6%) believed that both men and
women should be responsible for family planning. Support for general contraception use by their female intimate
partners was prevalent at 80.0%, but only 33.9% reported that they would like their partners to use the implant in
the future, while 35.6% were unsure and 30.5% did not support their partner’s use of the implant. Factors
significantly associated with men’s support of their partner’s future use of the contraceptive implant included men’s
reports that their partner wished to have another child in future, knowledge that the implant is safe for use by
women who have not had children, knowledge that the implant can effectively prevent pregnancy for 3 years, and
a positive attitude towards the implant’s long-lasting effectiveness.
Conclusion: Improving men’s knowledge of, and attitudes toward the contraceptive implant might increase their
support for their partner’s use of the implant, which in turn might promote uptake of the implant among women.
The findings of our study suggest the importance of actively engaging men in reproductive health and family
planning programs.
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Introduction
Family planning services have been available at no cost
in public health services in South Africa since 1994, and
now include the long-acting reversible contraceptives
(LARCs) namely, the contraceptive implant and intra-
uterine device (IUD). The Department of Health’s (DoH)
policy on contraception and fertility planning, updated
in 2014, expanding the method mix to give women
greater choice for family planning [1]. According to the
policy, “the methods of contraception were expanded to
cover an increased access to LARC methods with with
specific consideration of: increasing access to the copper
intrauterine device (Cu IUD), with antibiotics at the time
of insertion, and introduction of a single-rod progesto-
gen implant…” [1]. The contraceptive implant, Implanon
NXT, was the most common LARC on offer in South
African public health services at no cost. It is a subder-
mal single-rod implant containing 68mg of the proges-
tin etonogestrel, which is highly effective in preventing
pregnancy for a period of 3 years [2–4]. Despite the ro-
bust and supportive policies related to LARCs in the
public sector, the use of the contraceptive implant
among women is limited [5–7].
Among women, limited knowledge and awareness
of the different contraceptive methods, including the
implant, have been identified [7]. Additionally, con-
cerns, myths and misconceptions about side effects
and risks associated with the implant contribute to
the limited uptake among women [8–10]. Research
conducted among men on family planning use and
support remains insufficient globally [11]. The few
studies that have been conducted among men, show
that male partner support for family planning influ-
ences women’s behaviour towards the use of modern
contraceptives [11–14]. One study has been under-
taken among women showing that beliefs about and
perceptions of the implant’s side effects negatively in-
fluence men’s support for its use by their female in-
timate partners [15]. Another South African study
found that women report lack of male partner sup-
port for the use of the implant as one of the reasons
for early removal and discontinuation of use [16].
This study aims to describe the specific factors affect-
ing men’s support for the future use of the contraceptive
implant by their female intimate partners. Such an un-
derstanding can complement the women’s perceptions
of male partner support for family planning use and help
design specific interventions to ameliorate the challenges
affecting the implant use among women. Improving the
implant uptake may significantly reduce unintended
pregnancies which are highly prevalent among adoles-
cents and adults in the country [7, 17]. Ultimately, this
study hopes to contribute towards the intervention pro-
gram development for the reduction of unplanned and
or unintended pregnancies, as well as the unmet need
for contraception in the country.
Methods
Research design and study setting
This quantitative, cross-sectional survey was conducted
among adult men attending a public, primary health
clinic in Cape Town, South Africa. The clinic was se-
lected because it is a typical public clinic in a poor, peri-
urban setting. It offered a range of public primary health
services with a primary focus on STI, HIV and Tubercu-
losis (TB) services, including other sexual and repro-
ductive health services. It is worth noting that
historically, men poorly attend health care facilities and
often delay seeking health care services when they are ill
for various reasons, such as discomfort with female staff
nurses, clinics being full of women, and fear of being la-
belled as “weak” according to gender norms [18–20].
Consequently in South Africa, “men only” clinics were
initiated to help attract more men seeking health care
service, particularly for STI testing and treatment includ-
ing HIV services. This specific clinic, though not a “spe-
cialized” male clinic, it also had a “men only” section for
STI treatment with dedicated male providers. Despite
this effort, there were still few men attending the clinic.
Participant sampling
All men aged 18 years and above who were attending
the clinic between February 2015 to February 2016 for
sexual and reproductive health related services, including
HIV and TB testing and treatment were invited to par-
ticipate in this study. Although this study was conducted
in a public health clinic which also included a “men
only” section, very few men visited the clinic. Addition-
ally, to be invited in the study, men had to be able to
read and write in English or isiXhosa; not psychologic-
ally and or visually impaired. Hence, only 71 men were
approached and recruited for this study over this period.
Of the 71 sampled participants, 65 agreed to participate
and completed the self-administered questionnaire.
Those who declined to participate cited time constraints
as the main reason.
Data collection tool
A paper-pencil questionnaire format, requiring approxi-
mately 10 min for completion, was used to collect data.
Participants could complete it in their preferred lan-
guage (either English or Xhosa). Because of the sensitive
nature of the questions, we offered self-administered
survey completion to give participants privacy to answer
the questions as truthfully as possible.
Demographic questions included marital or relation-
ship status, and whether they had main or casual sex
partners, or both. A main sexual partner was defined as
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a sexual partner an individual has for six or more
months and included wives while a casual partner was
defined as a “secret” sexual partner an individual has sex
with occasionally and included the “one-night-stands”.
We included questions on partner’s use of family plan-
ning methods, as well as knowledge and awareness of,
and outcome expectancies related to the contraceptive
implant. We also included questions about the number
of pregnancies for the female intimate partner, and fer-
tility intentions. We asked whether participants had
heard of each of the different types of contraceptive
methods, the sources of information about each method
(health worker, friend, media, other), and whether the
participant knew if his female intimate partner had ever
used each method or was currently using it.
To assess knowledge of the contraceptive implant, par-
ticipants were provided with a set of six statements re-
garding the safety (e.g., ‘Most women can safely use the
implant’) and efficacy of the implant (e.g., ‘The implant
is very effective in preventing pregnancy). A three-point
Likert scale was used (agree, disagree, and unsure). The
internal consistency of the knowledge composite scale
was adequate (Cronbach’s Alpha: 0.64; 95% Confidence
Interval (95% CI): 0.60–0.69).
To measure outcome expectancies of the contraceptive
implant, participants were asked to imagine how it
would be like for them if their female intimate partners
were to use the implant. They were provided with eleven
(11) statements each reflecting a positive or negative
outcome expectancy (e.g., ‘I think that if my partner
were to use the implant it would be very good because it
lasts for a long time’ [positive] and ‘I think that if my
partner were to use the implant, the implant would
move around her body [negative]). A three-point Likert
scale was used (agree, disagree, or unsure). Finally, to
measure men’s support for their female intimate part-
ners to use the implant in the future, participants were
asked whether they would like their partners to use the
implant in the future (response options: yes, no, or un-
sure). The implant was defined to the participants as a
small plastic rod inserted under the skin of a woman’s
arm to prevent pregnancy. A copy of the questionnaire
with the full statements is provided as an additional file
[Additional file 1: Questionnaire]. Participants were of-
fered a nominal reimbursement, a chocolate bar, for
their time taken completing the survey.
Data analysis
Prior to analysis, items were rescored so that the valid
knowledge statements and positive attitudes scored
highest. Separate total scale scores were composed from
the six items of knowledge composite and from the 11
items of the men’s outcome expectancy composite for
the implant use by their female intimate partners.
However, the scale scores were not used in the analyses
due to the low internal reliability as indicated by the
Cronbach’s Alpha statistic.
Data were analyzed using SPSS version 25. Descriptive
statistics were performed to get an overview of the sam-
ple characteristics. A chi-square test was conducted to
explore the associations between the demographic char-
acteristics, knowledge scale, outcome expectancy items,
and whether or not the men would like their female in-
timate partners to use the implant in the future. Signifi-
cance level was set at p- value of equal to, or less than
0.05 (p ≤ 0.05). Prior to conducting the chi-square test,
some variables were collapsed to become dichotomous
variables. This was done in order to ascertain non-
violation of the minimum expected cell frequency for
the chi-square test. Thus, a 2 by 2 table design was used
in this study.
Results
A total of 65 men aged from 19 to 52 years with the
mean (SD) of 31.2 (8.4) participated in this study. A
small proportion, 23.1% (n = 15) were 24 years old or
younger. Most had not completed secondary education
(41.5%; n = 30) and 38.5% (n = 25) had completed sec-
ondary schooling. Only 15.4% (n = 10) had post-
secondary school education. Most participants, 59.4%,
(n = 38) reported they were unemployed. Most men,
87.2% (n = 56) were unmarried, but 81.3% (n = 52) re-
ported to have a main sex partner and 43.8% (n = 28) re-
ported to have a casual sex partner, while 18.8% (n = 12)
did not have a main or casual partner. The reported rea-
sons for being at the clinic on the day were for STI
treatment by 61.5% (n = 40), 35.4% (n = 23) for an HIV
test, and 4.6% (n = 3) for family planning.
Most participants, 76.6% (n = 49) endorsed the state-
ment that both men and women should be responsible
for family planning and 73.8% (n = 48) believed that men
and women should decide together whether a woman
should use contraception or not. Support for general
contraception use by their female intimate partners was
prevalent at 80.0% (n = 54). Awareness of the implant
among men was relatively low, with 52.3% (n = 34)
reporting they had never heard of the implant. Among
those who had heard about the implant, 51.6% (n = 15)
had heard about it from a friend, 32.3% (n = 10) from
the healthcare worker and 32.3% (n = 10) from had
heard about it from the media. Only 12.3% (n = 8) re-
ported that their partners had used the implant before
while the majority, 47.7% (n = 31) said their partners had
never used the implant to their knowledge, and 38.5%
(n = 25) said they did not know if their partners had ever
used it. After having been informed by the data collector
about the implant, 33.9% (n = 20) reported that they
would like their partners to use the implant in the
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future, while 35.6% (n = 21) were unsure and 30.5% (n =
18) said they would not like their partners to use it.
Table 1 below compares men who reported they sup-
ported their partner using the implant in the future with
those who did not support it or were unsure. Factors
significantly associated with men’s support included
men’s reports that their partner wished to have another
child in future, knowledge that the implant is safe for
use by women who have not had children, knowledge
that the implant can effectively prevent pregnancy for 3
years, and the positive expectancy of the implant’s long-
lasting effectiveness.
Discussion
This study investigated factors associated with men’s
support for the future use of the implant by their female
intimate partners. Among the men, there were relatively
low levels of awareness about the implant and minimal
support for its future use by their female intimate part-
ners. However, support for general contraceptive use
was high among the men in this study. Factors associ-
ated with men’s support for the future use of the im-
plant by their female intimate partners included: a) men
knowing that the intimate partner wishes to have an-
other child in future, b) knowing that the implant is safe
for use by women who have not had children yet, c)
knowing the timeframe within which the implant can ef-
fectively prevent pregnancy, and d) the perception that
the implant last long. These findings are not unique,
previous studies conducted elsewhere among men on
women’s contraceptive use also identified a strong asso-
ciation between men’s awareness of contraceptive
methods and their support for female intimate partner
use [21–28]. Furthermore, men’s awareness of and sup-
port for modern contraceptive use was strongly associ-
ated with women’s desire to use contraception in
Nigeria [21], and in Uganda [26]. Potentially, men may
play an essential role in some women’s decision to use
or not use contraception. Therefore, to improve men’s
support for the use of the contraceptive implant by their
female intimate partners, they need to be engaged with
as well if efforts to improve the uptake of the implant
among women in the country are to be realized. Thus,
efforts to improve men’s knowledge and awareness of
the implant could potentially improve women’s
utilization of the contraceptive implant.
It is not clear why men who believe their partners
want to have children in the future would be more likely
to support the implant use. It is possible that the men’s
fertility intentions were not aligned to their partner’s in-
tentions, and they regarded the implant as an effective
contraception. It is equally plausible that they supported
their partner’s use of the implant because of its
reversable attribute, enabling their partner to become
pregnant when the couple so desired.
It is well known that more women than men attend
health facilities for reproductive healthcare services in-
cluding family planning, but very little is being done to
improve men’s participation and involvement in repro-
ductive health programmes in the country. Men do not
come with their female intimate partners for family
planning [5]. Therefore, most men, as well as some
women generally have insufficient knowledge and under-
standing of female contraceptive methods, including the
implant but men are hardly ever reached compared to
women and continue to be distant in family planning
programming. The findings of our study suggest the im-
portance of actively engaging men in reproductive health
and family planning programs, and the potential that
men’s support could have on improving contraceptive
use among women.
There are, of course, some important limitations in
interpreting the findings of this study. The cross-
sectional nature of the study being the first important
one, cannot infer causality, meaning that improving
men’s knowledge and awareness of the contraceptive im-
plant will not necessarily result to improved uptake of
the implant by the women. The other limitations are the
small sample size of the men in this study, as well as the
setting in which this study was undertaken and there-
fore, the findings cannot be generalizable. It is possible
that most men were attending the “specialized” men
only clinics where they will not be seen by female pro-
viders as well as not be amongst the many female pa-
tients who are filling up the waiting rooms in public
health facilities [19]. Despite these limitations, the find-
ings of this study highlight the need and importance of
actively engaging men in reproductive health program-
ming to improve contraceptive uptake and reduce the
unmet need for contraception among women of repro-
ductive age.
Conclusion
Men’s perceptions about the implant’s safety and long-
lasting characteristics are associated with their support
for the future use of the implant by their female intimate
partners. Thus, improving knowledge and awareness of
the contraceptive implant among men may be a step in
the right direction towards improving the uptake of the
implant by women in the country. Unless men are well-
informed and involved in reproductive health or family
planning programming, support for their female intimate
partners to use contraception will remain a challenge for
many women. Interventions and strategies to engage
men in family planning programs and enhance their par-
ticipation in these programs are needed.
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Table 1 Associations between selected demographic characteristics, knowledge and outcome expectancy of the implant against
whether the men would like their female intimate partners to use the implant in the future, Chi-Square results








< 25 years old 3 (21.4%) 11 (78.6%)
> 25 years old 17 (37.8%) 28 (62.2%)
1.27 (.26)
Education
Up to incomplete secondary school 11 (40.7%) 16 (59.3%)
Secondary school and post-secondary 9 (28.1%) 23 (71.9%)
1.04 (.31)
Family planning responsibility and support
Who is responsible for FP
Woman or man 5 (35.7%) 9 (64.3%)
Both man and woman 15 (33.3%) 30 (66.7%)
.03 (.87)
Who should decide a woman should use FP
Woman or man 7 (46.7%) 8 (53.3%)
Both man and woman 13 (29.5%) 31 (70.5%)
1.46 (.23)
How do you feel about your partner using FP
Support partner 17 (34.7%) 32 (65.3%)
I don’t like it 2 (50.0%) 2 (50.0%)
.88 (.35)
Does your main partner/wife want a/another child
Yes 14 (51.9%) 13 (48.1%)
No or unsure 6 (18.8%) 26 (81.2%)
7.16 (.01)
Knowledge composite
Most women can safely use the implant
Agree 13 (50.0%) 13 (50.0%)
Disagree or unsure 7 (21.2%) 26 (78.8%)
5.38 (.02)
Teenagers can safely use the implant
Agree 13 (44.8%) 16 (55.2%)
Disagree or unsure 7 (23.3%) 23 (76.7%)
3.04 (.08)
Women with no babies can safely use the implant
Agree 11 (40.7%) 16 (59.3%)
Disagree or unsure 9 (28.1%) 23 (71.9%)
1.04 (.31)
HIV positive women can safely use the implant
Agree 11 (47.8%) 12 (52.2%)
Disagree or unsure 9 (25.0%) 27 (75.0%)
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Table 1 Associations between selected demographic characteristics, knowledge and outcome expectancy of the implant against
whether the men would like their female intimate partners to use the implant in the future, Chi-Square results (Continued)







Implant is very effective in preventing pregnancy
Agree 12 (40.0%) 18 (60.0%)
Disagree or unsure 8 (27.6%) 21 (72.4%)
1.01 (.31)
Implant can prevent pregnancy for:
About 3 years 9 (56.2%) 7 (43.8%))
Don’t know or otherb 11 (25.6%) 32 (74.4%)
4.89 (.03)
Implant protects against STIs and HIV
Agree 4 (28.6%) 10 (71.4%)
Disagree or unsure 16 35.6%) 29 (64.4%)
.23 (.63)
Outcome expectancy composite
Implant could be easily inserted
Agree 10 (29.4%) 15 (70.6%)
Disagree or unsure 10 (29.4%) 24 (70.6%)
7.2 (.39)
Implant could be easily removed
Agree 8 (38.1%) 13 (61.9%)
Disagree or unsure 12 (31.6%) 26 (68.4%)
.26 (.61)
Implant is convenient
Agree 14 (42.4%) 19 (57.6%)
Disagree or unsure 6 (23.1%) 20 (76.9%)
2.43 (.12)
Implant lasts for long
Agree 14 (46.7%) 16 (53.3%)
Disagree or unsure 6 (20.7%) 23 (79.3%)
4.44 (.04)
I’d worry about her gaining weight if she uses the implant
Agree 10 (43.5%) 13 (56.5%)
Disagree or unsure 10 (27.8%) 26 (72.2%)
1.54 (.21)
I’d worry about her monthly bleeding if she uses the implant
Agree 5 (41.7%) 7 (58.3%)
Disagree or unsure 15 (31.9%) 32 (68.1%)
.41 (.52)
Implant could stop her from falling pregnant even after she removes it
Agree 8 (50.0%) 8 (50.0%)
Disagree or unsure 12 (27.9%) 31 (72.1%)
2.27 (.13)
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